Veröffentlichungen

Literatur

Gerhauser C. Beer constituents as potential cancer chemopreventive agents. European Journal of Cancer 41, 1941-1954 (2005)

Gross-Steinmeyer K., Spapelton Pl, Liu F et al.: Phytochemical-induced changes in gene expression of carzinogen-metabolizing enzymes in cultured human primary hepatocytes. Xenobiotica 34, 619-632 (2004)

Miranda Cl, Stevens JF, Ivanov V, et al.: Antioxidant and prooxidant actions of prenylated and non prenylated chalcones and flavonons in vitro. J Agric Food Chem 48, 3876-3884 (2000)

Rodriguez Rj, Miranda Cl, Stevens JF, et al.: Influence of prenylated and non prenylated flavonoids on liver microsomal liquid peroxidation and oxidative injury in rat hepatocytes. Food Chem Toxical 39, 437-445 (2001)

Stevens JF, Miranda Cl, Frei B, et al.: Inhibition of peroxynitrite-mediated LDL oxidation by prenylated flavonoids: the alpha, beta-unsaturated keto functionality of 2?-hydroxychalcones as a novel antioxidant pharmacophore. Chem Res Toxicol 16, 1277-1286 (2003)

Goto K, Asai T, Hara S, et al.: Enhanced antitumor activity of xanthohumol, a diacylglycerol acyltransferase inhibitor, under hypoxia. Cancer Lett 219, 215-222 (2005)

Bertl E, Herhaus C, Kapadia G, et al.: Inhibition of endothelial cell functions by novel potential anti-angiogenic agents. Biochem Biophys Res Commun 325, 287-295, 2004

Bertl E: Inhibition of angiogenesis by potential cancer chemopreventive agents – Esstablished of a human in vitro anti-angiogenesis assay mechanistic evaluation of potent inhibitors. Ph.D. Thesis University of Heidelberg, 2005

Buckwold VE, Wilson RJ, Nalca A, et al.: Antiviral activity of hop constitutents against a series of DNA and RNA viruses. Antiviral Res 61, 57-62, 2004

Wang Q, Ding ZH, Liu JK et al.: Xanthohumol, a novel anti-HIV-1 agent purified from hops Humulus lupulus, Antiviral Res 64, 189-194, 2004

Gerhauser C, Alt A, Heiss E, Gamal-Eldeen A, Klimo K, Knauft J, Newman H, Scherf Hr, Frank N, Bartsch H, Becker H: Cancer Chemopreventive Activity of Xanthohumol, a Natural Product Derived from Hop. Molekular Cancer Therapeutic, 1, 959-969 (2000)

Henderson MC, Miranda CL, Stevens JF, Deinzer ML, Buhler DR: In vitro inhibition of human p450 enzymes by prenylated flavonoides from hops, Humulus lupulus. Xenobiotica 30, 235-251 (2000)

Miranda CL, Stevens JF, Helmrich A, Henderson MC, Rodriguez RJ, Young YH, Deinzer ML, Barnes DW and Buhler DR: Antiproliferative and cytotoxic effects of prenylated flavonoids from hops (Humulus lupulus L.) in human cancer cell lines. Food Chem. Toxicol 37, 271-285 (1999)

Miranda CL, Young YH, Henderson MC, Stevens JF, Santana G, Deinzer ML, Buhler DR: Prenylflavonoids from Hops Inhibit thr Metabolic Activation of the Carcinogenic Heterocyclic Amine, 2-Amino-3methyllimidazo(4,5f)quinoline (IQ), mediated by cDNA-Expressed Human CYP1A2. Drug Metab. Dispos, 28, 1297-1302 (2000)

Tabata N, Ito M, Tomoda H and Umur S: Xanthohumols, diacylglycerol acyltransferase inhibitors, from Humulus Lupulus. Phytochemistry 46, 683-687 (1997)

Demulle L, Bellahcene A, Dhooge W, Comhaire F, Roelens F, Huvaere K, Hyerick A, Castronovo V, De Keukeleire D, Anti-proliferative properties of prenylated flavonoids from hops (Humulus lupulus L.) in human prostate cancer cell lines, Phytomedicine, 13, 732-734 (2006)

Colgate EC, Miranda CL, Stevens JF, Bray TM, Ho E. Xanthohumol, a prenylflavonoid derived from hops induces apoptosis and inhibits NF-kappaß activation in prostate epithelial cells. Cancer Letters, 246, 201-209

Albini A, Dell?Eva R, Vene R, Ferrari N, Buhler DR, Noonan DM, Fassina G. Mechanisms of the antiangiogenic activity by the hop flavonoid xanthohumol: NF-kappaß and Akt as targets. Faseb J. 20, 527-529 (2007)

Nozawa H., Xanthohumol, the chalcone from beer hops (Humulus lupulus L.), is the ligand for farnesoid X receptor and ameliorates lipid and glucose metabolism in KK-A(y) mice. Biochemical and Biophysical Research Communications, 336, 754-761 (2005)

Gerhäuser C., Broad spectrum anti-infective potential of xanthohumol from hop (Humulus lupulus L.) in comparison with activities of other hop constituents

  1. Bartsch, N. Frank, A. Gamal-Eldeen, C. Gerhäuser, E. Heiss, K. Klimo, J. Knauft, I. Neumann, H. Scherf (Deutsches Krebsforschungszentrum (DKFZ), Abteilung Toxikologie und Krebsrisikofaktoren, Heidelberg), A. Alt, H. Becker, A. Nookandeeh (Pharmakognosie und Analytische Phytochemie, Universität des Saaarlandes, Saarbrücken): Isolierung von Xanthohumol, einem prenylierten Chalcon aus Hopfen (Humulus lupulus L.) mit Krebs-chemopräventiver Wirkung. Hopfenrundschau International 44-55 (2002/2003).

Schmandke H.: Prenylflavonoide in Hopfen und Bier – ihre biochemischen und biologischen Effekte. Ernährungsumschau 53 Heft 6, 225-229, 2006

Harnisch, Günter: Cystus – Gesundheit und Schönheit aus der griechischen Wildpflanze. Verlag Lorber und Turm, 2000